Madrigal Pharmaceuticals (MDGL) Capital Expenditures (QoQ) (2010 - 2026)
Madrigal Pharmaceuticals (MDGL) Capital Expenditures (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Madrigal Pharmaceuticals |
14.67 Bn |
14.44 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
1,574.71% |
| Dec 31, 2025 |
-135.85% |
| Dec 31, 2024 |
399.59% |
| Sep 30, 2024 |
-472.52% |
| Jun 30, 2024 |
-63.31% |
| Mar 31, 2024 |
-65.54% |
| Dec 31, 2023 |
205.60% |
| Sep 30, 2023 |
391.30% |
| Jun 30, 2023 |
97.14% |
| Mar 31, 2023 |
20.69% |
| Dec 31, 2022 |
-12.12% |
| Sep 30, 2022 |
-67.96% |
| Jun 30, 2022 |
98.08% |
| Mar 31, 2022 |
-53.98% |
| Dec 31, 2021 |
126.00% |
| Sep 30, 2021 |
2,400.00% |
| Jun 30, 2021 |
-95.45% |
| Mar 31, 2021 |
340.00% |
| Dec 31, 2020 |
233.33% |
| Sep 30, 2020 |
-57.14% |
